Pancreatic Cancer
Show only recruiting trials?

SSP-20-006
(SALTKIVA)
A Phase 2 Study of Saltikva (Attenuated Salmonella Typhimurium Containing the Human Gene for Interleukin-2) in Patients With Metastatic Pancreatic Cancer
Status
Recruiting
JCP
JCP089
NCT
NCT04589234

OZM-101 | NeoPancOne
GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma (NeoPancOne)
Status
Opening Soon
JCP
Pending
NCT
NCT04472910

PA.6
Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
Status
Closed to Accrual
JCP
PA.6
NCT
NCT01526135

PA.7
A Randomized Phase II Trial of Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma
Status
Closed to Accrual
JCP
PA.7
NCT
NCT02879318
Filter Clinical Trials by:
Biomarkers: